We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
The When and How of Implementing New Anti-Neutrophil Therapies Into Standard Clinical Practice
Pamela J. McShane, MD
Gregory Tino, MD
Ashwin Basavaraj, MD
Non-CF Bronchiectasis (NCFBE): Redefined
Colin Swenson, MD
Vortex Management: Multiprong and Individualized Treatment Approach
Caregiver Testimonial: A Day in the Life of the Bronchiectasis Patient
Jungae Kole, RN, BSN
Non-CF Bronchiectasis: Navigating the Chronic Cough Vortex
Vortex Management: Diagnostic Algorithm for the PCP and Specialist
The Neutrophil and Neutrophil Serine Proteases (NSPs) in Non-CF Bronchiectasis (NCFBE)
Phenotyping the ILD-PH Patient To Determine Treatment Strategy
Oksana A. Shlobin, MD
Rajan Saggar, MD
Sudarshan Rajagopal, MD, PhD
Advancing Diagnosis and Risk Assessment in PH
Richard N. Channick, MD
Jean M. Elwing, MD
Dinesh Khanna, MD, MS
Martha Kingman, FNP-C, DNP
Richard Krasuski, MD
Vallerie V. McLaughlin, MD
CTD-PAH: What Is the Focus in 2023?
What Echo Aspects are Essential to PH Diagnosis?
Screening and Diagnosis of PAH: Cardiopulmonary Exercise Testing (CPET)
Case: A 54-Year-Old Woman With Progressive Dyspnea
Will Lowering the Hemodynamic Threshold for PH Impact “Discovery” of New Patients?
Why Should We Screen for PAH in Systemic Sclerosis Patients?
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education